The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings: Clinical Benefits and Cost-effectiveness
Abstract
CONTEXT: Cervical cancer is a leading cause of cancer-related death among women in developing countries. In such low-resource settings, cytology-based screening is difficult to implement, and less complex strategies may offer additional options. OBJECTIVE: To assess the cost-effectiveness of several cervical cancer screening strategies using population-specific data. DESIGN AND SETTING: Cost-effectiveness analysis using a mathematical model and a hypothetical cohort of previously unscreened 30-year-old black South African women. Screening tests included direct visual inspection (DVI) of the cervix, cytologic methods, and testing for high-risk types of human papillomavirus (HPV) DNA. Strategies differed by number of clinical visits, screening frequency, and response to a positive test result. Data sources included a South African screening study, national surveys and fee schedules, and published literature. MAIN OUTCOME MEASURES: Years of life saved (YLS), lifetime costs in US dollars, and incremental cost-effectiveness ratios (cost per YLS). RESULTS: When analyzing all strategies performed as a single lifetime screen at age 35 years compared with no screening, HPV testing followed by treatment of screen-positive women at a second visit, cost $39/YLS (27% cancer incidence reduction); DVI, coupled with immediate treatment of screen-positive women at the first visit was next most effective (26% cancer incidence reduction) and was cost saving; cytology, followed by treatment of screen-positive women at a second visit was least effective (19% cancer incidence reduction) at a cost of $81/YLS. For any given screening frequency, when strategies were compared incrementally, HPV DNA testing generally was more effective but also more costly than DVI, and always was more effective and less costly than cytology. When comparing all strategies simultaneously across screening frequencies, DVI was the nondominated strategy up to a frequency of every 3 years (incremental cost-effectiveness ratio, $460/YLS), and HPV testing every 3 years (incremental cost-effectiveness ratio, $11 500/YLS) was the most effective strategy. CONCLUSION: Cervical cancer screening strategies that incorporate DVI or HPV DNA testing and eliminate colposcopy may offer attractive alternatives to cytology-based screening programs in low-resource settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Estimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Estimates of the worldwide mortality from 25 cancers in 1990
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<18::aid-ijc5>3.0.co;2-m · Cited by 1,549
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Nanda, K., McCrory, D. C., Myers, E. R., Bastian, L. A., Hasselblad, V., Hickey, J. D., & Matchar, D. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-10-200005160-00009 · Cited by 1,089
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991210)83:6<870::aid-ijc35>3.0.co;2-9 · Cited by 860
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Nobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Meta-analysis of Pap Test Accuracy
Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 684
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Natural History of Dysplasia of the Uterine Cervix
Holowaty, P., Miller, A. B., Rohan, T., & To, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.252 · Cited by 608
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.6.464 · Cited by 586
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
Sun, X.-W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J., & Wright, T. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371903 · Cited by 543
Self-citationPalefsky, J. M., Minkoff, H., Kalish, L. A., Levine, A., Sacks, H. S., Garcia, P., Young, M., Melnick, S., Miotti, P., & Burk, R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.226 · Cited by 537
Wallin, K.-L., Wiklund, F., Ångström, T., Bergman, F., Stendahl, U., Wadell, G., Hallmans, G., & Dillner, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412201 · Cited by 493
Incidence of Cervical Squamous Intraepithelial Lesions in HIV-Infected Women
Ellerbrock, T. V. (2000) · JAMA · doi:10.1001/jama.283.8.1031 · Cited by 480
Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470
Wright, Jr. (2000) · JAMA · doi:10.1001/jama.283.1.81 · Cited by 468
Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M., & Kenemans, P. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610305 · Cited by 368
Statistical analysis of the stages of HIV infection using a Markov model
Longini, I. M., Clark, W. S., Byers, R. H., Ward, J. W., Darrow, W. W., Lemp, G. F., & Hethcote, H. W. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080708 · Cited by 304
Soloman, D. (1989) · Diagnostic Cytopathology · doi:10.1002/dc.2840050318 · Cited by 289
Strategies for global control of cervical cancer
Pontén, J., Adami, H., Bergström, R., Dillner, J., Friberg, L., Gustafsson, L., Miller, A. B., Parkin, D. M., Sparén, P., & Trichopoulos, D. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600102 · Cited by 289
HPV testing in primary screening of older women
Cuzick, J., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A., Chan, W.-K., Krausz, T., & Soutter, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690730 · Cited by 268
Sellors, J. W., Lorincz, A. T., Mahony, J. B., Mielzynska, I., Lytwyn, A., Roth, P., Howard, M., Chong, S., Daya, D., Chapman, W. B., et al. (2000) · Europe PMC (PubMed Central) · Cited by 256
Evaluation of alternative methods of cervical cancer screening for resource-poor settings
Denny, L., Kuhn, L., Pollack, A., Wainwright, H., & Wright, T. C. (2000) · Cancer · doi:10.1002/1097-0142(20000815)89:4<826::aid-cncr15>3.0.co;2-5 · Cited by 253
Self-citationConfronting AIDS: Public Priorities in a Global Epidemic
Bongaarts, J. (1998) · Population and Development Review · doi:10.2307/2807998 · Cited by 245
Rozendaal, L., Walboomers, J. M. M., van der Linden, J. C., Voorhorst, F. J., Kenemans, P., Helmerhosrt, T. J. M., van Ballegooijen, M., & Meijer, C. J. L. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961211)68:6<766::aid-ijc13>3.0.co;2-z · Cited by 244
The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections
Freedberg, K. A. (1998) · JAMA · doi:10.1001/jama.279.2.130 · Cited by 243
Follen Mitchell, M. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00246-4 · Cited by 231
Sankaranarayanan, R., Wesley, R., Somanathan, T., Dhakad, N., Shyamalakumary, B., Amma, N. S., Parkin, D. M., & Nair, M. K. (1998) · Cancer · Cited by 227
Clavel, C., Masure, M., Bory, J.-P., Putaud, I., Mangeonjean, C., Lorenzato, M., Gabriel, R., Quereux, C., & Birembaut, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690523 · Cited by 225
Londesborough, P., Ho, L., Terry, G., Cuzick, J. M., Wheeler, C. M., & Singer, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961021)69:5<364::aid-ijc2>3.3.co;2-u · Cited by 224
Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings
Kuhn, L., Denny, L., Pollack, A., Lorincz, A., Richart, R. M., & Wright, T. C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.818 · Cited by 217
Self-citationCuzick, Sasieni, Davies, Adams, Normand, Frater, van Ballegooijen, & van den Akker (1999) · Health Technology Assessment · doi:10.3310/hta3140 · Cited by 204
Evaluation of cervical cytology.
McCrory, D., Matchar, D. B., Bastian, L., Datta, S., Hasselblad, V., Hickey, J., Myers, E. R., & Nanda, K. (1999) · PubMed Central · Cited by 196
Gilson, L., Mkanje, R., Grosskurth, H., Mosha, F., Picard, J., Gavyole, A., Todd, J., Mayaud, P., Swai, R., Fransen, L., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08222-6 · Cited by 184
FIGO staging of gynecologic cancer
Pecorelli, S., Benedet, J. L., Creasman, W. T., Shepherd, J. H., & on behalf of the 1994–1997 FIGO Committee on Gynecologic Oncology (1999) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(99)00070-3 · Cited by 179
An overview of cancer survival in developing countries.
Sankaranarayanan, R., Rj, B., Swaminathan, R., & Dm, P. (1998) · PubMed · Cited by 153
Syrjänen, K. J., Kataja, V. V., Yliskoski, M. H., Chang, F., Syrjänen, K. J., & Saarikoski, S. (1992) · PubMed · Cited by 152
Survival From Early, Intermediate, and Late Stages of HIV Infection
Enger, C. L. (1996) · JAMA · doi:10.1001/jama.1996.03530410043031 · Cited by 120
Natural history and spectrum of disease in adults with HIV/AIDS in Africa.
Grant, A. D., Djomand, G., & Km, D. C. (1997) · PubMed · Cited by 119
Goldie, S. J., Weinstein, M. C., Kuntz, K. M., & Freedberg, K. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-2-199901190-00003 · Cited by 105
Self-citationAssessing the effectiveness of health interventions for cost-effectiveness analysis
Mandelblatt, J. S., Fryback, D. G., Weinstein, M. C., Russell, L. B., & Gold, M. R. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.07107.x · Cited by 104
Survival from early, intermediate, and late stages of HIV infection.
Enger, C. L., Graham, N. M. H., Peng, Y. W., et al. (1996) · PubMed · Cited by 103
Screening for cervical neoplasia by self-assessment for human papillomavirus DNA
Hillemanns, P., Kimmig, R., Hüttemann, U., Dannecker, C., & Thaler, C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04110-0 · Cited by 102
Serwadda, D., Wawer, M. J., Shah, K. V., Sewankambo, N. K., Daniel, R. W., Li, C., Lorincz, A. T., Meehan, M. P., Wabwire‐Mangen, F., & Gray, R. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315026 · Cited by 97
HPV-based cervical cancer screening in a population at high risk for HIV infection
Womack, S. D., Chirenje, Z. M., Gaffikin, L., Blumenthal, P. D., McGrath, J. A., Chipato, T., Ngwalle, S., Munjoma, M. W., & Shah, K. V. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000115)85:2%3c206::aid-ijc10%3e3.0.co;2-q · Cited by 80
Can papilloma virus testing be used to improve cervical cancer screening?
Jenkins, D., Sherlaw‐Johnson, C., & Gallivan, S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6<768::aid-ijc10>3.0.co;2-0 · Cited by 79
Detection of cervical intraepithelial neoplasia in developing countries
Kitchener, H. C., & Symonds, P. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00417-6 · Cited by 66
Early detection of cervical cancer by visual inspection: A population-based study in rural India
Nene, B. M., Deshpande, S. A., Jayant, K., Budukh, A. M., Dale, P. S., Deshpande, D. A., Chiwate, A. S., Malvi, S. G., Deokar, S., Parkin, D. M., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961211)68:6<770::aid-ijc14>3.0.co;2-4 · Cited by 62
Two-stage cervical cancer screening: An alternative for resource-poor settings
Denny, L. E., Kuhn, L., Risi, L., Richart, R. M., Pollack, A. E., Lörincz, A. T., Kostecki, F., & Wright, T. C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.105871 · Cited by 58
Self-citationCryosurgery in the management of cervical intraepithelial neoplasia.
Creasman, W. T., Hinshaw, W. M., & Clarke‐Pearson, D. L. (1984) · PubMed · Cited by 51
Carcinoma of the cervix in the African setting
Rogo, K. O., Omany, J., Onyango, J., Ojwang, S. B., & Stendahl, U. (1990) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(90)90010-i · Cited by 49
Collection devices for human papillomavirus.
Harper, D. M., Hildesheim, A., Cobb, J. L., Greenberg, M., Vaught, J., & Lorincz, A. T. (1999) · PubMed · Cited by 49
Evaluating cervical cancer screening programmes for developing countries
Sherlaw‐Johnson, C., Gallivan, S., & Jenkins, D. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970717)72:2<210::aid-ijc2>3.0.co;2-u · Cited by 48
Visual Inspection With Acetic Acid in Cervical Cancer Screening
Ardahan, M., & Temel, A. B. (2010) · Cancer Nursing · doi:10.1097/ncc.0b013e3181efe69f · Cited by 46
Trends in Cervical Cancer Mortality in South Africa
Bailie, R. S., Selvey, C., Bourne, D., & Bradshaw, D. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.3.488 · Cited by 41
&NA; (1990) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199002000-00021 · Cited by 32
Cryosurgery for cervical intraepithelial neoplasia: 10-year follow-up
Andersen, E. S., & Husth, M. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90297-v · Cited by 26
Human Papillomavirus Testing as a Screening Tool for Cervical Cancer
Koss, L. G. (2000) · JAMA · doi:10.1001/jama.283.19.2525 · Cited by 26
Dorrington, R. (1998) · Open University of Cape Town (University of Cape Town) · Cited by 21
Human papillomavirus testing as a screening tool for cervical cancer
SCHIFFMAN, M. H., Hildesheim, A., Herrero, R., & Bratti, C. (2000) · PubMed · Cited by 19
(2001) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200101000-00015 · Cited by 8
Cited by
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
Effective screening programmes for cervical cancer in low- and middle-income developing countries.
(2001) · Europe PMC (PubMed Central) · Cited by 724
Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahé, C., & Wright, T. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044278 · Cited by 671
Self-citation
Metadata
- Authors
- Goldie, S. J., Kuhn, L., Denny, L., Pollack, A., & Wright, T. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-06-27
- Volume
- 285
- Issue
- 24
- Pages
- 3107
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2093924252
- Cited by
- 335
- References
- 68
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.